nach oben

Diabetologia

Erschienen in:

01.10.2006 | Article

The effect of diabetes and stroke at baseline and during follow-up on stroke mortality

verfasst von: G. Hu, P. Jousilahti, C. Sarti, R. Antikainen, J. Tuomilehto

Erschienen in: Diabetologia | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The aim of this study was to compare the magnitude of the effect of diabetes and stroke at baseline and during follow-up on risk of stroke mortality.

Materials and methods

Study cohorts included 25,155 Finnish men and 26,423 women aged 25–74 years. Data on diabetes and stroke history at baseline, their incidence during follow-up, and stroke death were obtained from national registers.

Results

During a mean follow-up of 18.9 years, 838 stroke deaths were recorded. In the baseline study, hazard ratios (HRs) for stroke mortality were 5.26 for men with prior diabetes only, 4.76 for men with prior stroke only, and 13.4 for men with both prior diabetes and stroke compared with men without diabetes and stroke at baseline and during follow-up. In women, the corresponding hazard ratios were 7.29, 5.27 and 5.52, respectively. When only diabetes and stroke status during the follow-up were considered, the hazard ratios for stroke mortality were 1.41 for men and 1.56 for women with incident diabetes only, 5.62 for men and 5.58 for women with incident stroke only, and 5.59 for men and 4.48 for women with both incident diabetes and stroke compared with men and women without diabetes and stroke at baseline and during follow-up.

Conclusions/interpretation

Diabetes and stroke, present either at baseline or during follow-up, markedly increase the risk of stroke death. Prior stroke at baseline carries a similar risk of stroke mortality as prior diabetes. There is a greater risk of stroke mortality associated with incident stroke during follow-up than with incident diabetes.

Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef

Muller WA (1998) Diabetes mellitus—long time survival. J Insur Med 30:17–27PubMed

DECODE Study Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405CrossRef

DECODE Study Group (2003) Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46:608–617CrossRef

Laakso M (2001) Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med 249:225–235PubMedCrossRef

Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234PubMedCrossRef

Hu FB, Stampfer MJ, Solomon CG et al (2001) The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161:1717–1723PubMedCrossRef

Lotufo PA, Gaziano JM, Chae CU et al (2001) Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 161:242–247PubMedCrossRef

Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL (2003) Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 163:1735–1740PubMedCrossRef

10.

Lee CD, Folsom AR, Pankow JS, Brancati FL (2004) Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 109:855–860PubMedCrossRef

11.

Vaccaro O, Eberly LE, Neaton JD et al (2004) Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med 164:1438–1443PubMedCrossRef

12.

Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J (2005) Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 48:856–861PubMedCrossRef

13.

Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J (2005) The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol 45:1413–1418PubMedCrossRef

14.

Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–444PubMedCrossRef

15.

Lehto S, Ronnemaa T, Pyorala K, Laakso M (1996) Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27:63–68PubMed

16.

Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E (1996) Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. Stroke 27:210–215PubMed

17.

Tanne D, Yaari S, Goldbourt U (1998) Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation 98:1365–1371PubMed

18.

Folsom AR, Rasmussen ML, Chambless LE et al (1999) Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care 22:1077–1083PubMedCrossRef

19.

Iso H, Imano H, Kitamura A et al (2004) Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women. Diabetologia 47:2137–2144PubMedCrossRef

20.

Lawes CM, Parag V, Bennett DA et al (2004) Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 27:2836–2842PubMedCrossRef

21.

Kissela BM, Khoury J, Kleindorfer D et al (2005) Epidemiology of ischemic stroke in patients with diabetes: the Greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 28:355–359PubMedCrossRef

22.

Hu G, Sarti C, Jousilahti P et al (2005) The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 36:2538–2543PubMedCrossRef

23.

Haheim LL, Holme I, Hjermann I, Leren P (1993) Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study. Stroke 24:1484–1489PubMed

24.

Simons LA, McCallum J, Friedlander Y, Simons J (1998) Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke 29:1341–1346PubMed

25.

Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P (2000) Cardiovascular risk factor changes in Finland, 1972–1997. Int J Epidemiol 29:49–56PubMedCrossRef

26.

WHO MONICA Project Principal Investigators (1988) The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 41:105–114CrossRef

27.

Hu G, Qiao Q, Silventoinen K et al (2003) Occupational, commuting, and leisure-time physical activity in relation to risk for type 2 diabetes in middle-aged Finnish men and women. Diabetologia 46:322–329PubMed

28.

Hu G, Barengo NC, Tuomilehto J, Lakka TA, Nissinen A, Jousilahti P (2004) Relationship of physical activity and body mass index to the risk of hypertension: a prospective study in Finland. Hypertension 43:25–30PubMedCrossRef

29.

Hu G, Lindstrom J, Valle TT et al (2004) Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 164:892–896PubMedCrossRef

30.

Hu G, Eriksson J, Barengo NC et al (2004) Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. Circulation 110:666–673PubMedCrossRef

31.

Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P (2004) Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J 25:2212–2219PubMedCrossRef

32.

Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J (2005) Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 36:1994–1999PubMedCrossRef

33.

Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J (2005) Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 28:799–805PubMedCrossRef

34.

Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P (2005) The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47,212 middle-aged Finnish men and women. Int J Obes (Lond) 29:894–902CrossRef

35.

Jousilahti P, Vartiainen E, Pekkanen J, Tuomilehto J, Sundvall J, Puska P (1998) Serum cholesterol distribution and coronary heart disease risk: observations and predictions among middle-aged population in eastern Finland. Circulation 97:1087–1094PubMed

36.

Leppälä JM, Virtamo J, Heinonen OP (1999) Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. Eur J Epidemiol 15:155–160PubMedCrossRef

37.

Mahonen M, Salomaa V, Keskimaki I et al (2000) The feasibility of combining data from routine Hospital Discharge and Causes-of-Death Registers for epidemiological studies on stroke. Eur J Epidemiol 16:815–817PubMedCrossRef

38.

WHO Study Group on Diabetes Mellitus (1985) Diabetes Mellitus: Report of a WHO Study Group. WHO Technical Report Series No 727. World Health Organization, Geneva

39.

WHO Consultation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus. Report of a WHO Consultation 99.2. World Health Organisation, Geneva

40.

Ho JE, Paultre F, Mosca L (2003) Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the women’s pooling project. Stroke 34:2812–2816PubMedCrossRef

41.

Hart CL, Hole DJ, Smith GD (2000) Comparison of risk factors for stroke incidence and stroke mortality in 20 years of follow-up in men and women in the Renfrew/Paisley Study in Scotland. Stroke 31:1893–1896PubMed

42.

Goldberg RB, Mellies MJ, Sacks FM et al (1998) Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 98:2513–2519PubMed

43.

Keech A, Colquhoun D, Best J et al (2003) Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial. Diabetes Care 26:2713–2721PubMedCrossRef

44.

Stratton IM, Adler AI, Neil HAW et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective Observational Study. BMJ 321:405–412PubMedCrossRef

45.

Curb JD, Pressel SL, Cutler JA et al (1996) Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 276:1886–1892PubMedCrossRef

46.

UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317:703–713

47.

Tuomilehto J, Rastenyte D, Birkenhager WH et al (1999) Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med 340:677–684PubMedCrossRef

48.

Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:614–620PubMedCrossRef

49.

Heart Protection Study Collaborative Group (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016CrossRef

50.

Colhoun HM, Betteridge DJ, Durrington PN et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696PubMedCrossRef

51.

Valle T, Tuomilehto J, Eriksson J (1997) Epidemiology of NIDDM in Europids. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H (eds) International Textbook of Diabetes Mellitus, 2nd edn. Wiley, London, pp 125–142

Titel: The effect of diabetes and stroke at baseline and during follow-up on stroke mortality
verfasst von: G. Hu
P. Jousilahti
C. Sarti
R. Antikainen
J. Tuomilehto
Publikationsdatum: 01.10.2006
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 10/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-006-0378-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Materials and methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2006

Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction

Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy

Diabetes and brain damage: more (or less) than meets the eye?

High glucose and homocysteine synergistically affect the metalloproteinases–tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts

Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study